SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cardlytics, Inc. – ‘8-K’ for 5/11/20

On:  Monday, 5/11/20, at 4:09pm ET   ·   For:  5/11/20   ·   Accession #:  1666071-20-127   ·   File #:  1-38386

Previous ‘8-K’:  ‘8-K’ on / for 3/10/20   ·   Next:  ‘8-K’ on / for 6/2/20   ·   Latest:  ‘8-K’ on / for 4/9/24

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/11/20  Cardlytics, Inc.                  8-K:2,9     5/11/20   13:566K

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     31K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    119K 
11: R1          Document and Entity Information                     HTML     49K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
13: XML         XBRL Instance -- cdlxform8-k2020q1resul_htm          XML     15K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.CAL  XBRL Calculations -- cdlx-20200511_cal               XML      7K 
 5: EX-101.DEF  XBRL Definitions -- cdlx-20200511_def                XML     39K 
 6: EX-101.LAB  XBRL Labels -- cdlx-20200511_lab                     XML     79K 
 7: EX-101.PRE  XBRL Presentations -- cdlx-20200511_pre              XML     42K 
 3: EX-101.SCH  XBRL Schema -- cdlx-20200511                         XSD     16K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               14±    21K 
12: ZIP         XBRL Zipped Folder -- 0001666071-20-000127-xbrl      Zip     49K

‘8-K’   —   Current Report

This is an HTML Document rendered as filed.  [ Alternative Formats ]

 iX:   C:   C:   C: 
  Document  
 i false i 0001666071 0001666071 2020-05-11 2020-05-11


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM  i 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):  i May 11, 2020
 
 
cardlytics_logoa27.jpg
 i CARDLYTICS, INC.
(Exact Name of Registrant as Specified in its Charter)
 
 i Delaware
 i 001-38386
 i 26-3039436
(State or other jurisdiction of
incorporation or organization)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
 i 675 Ponce de Leon Avenue NE, Suite 6000
 i Atlanta
 i Georgia
 i 30308
(Address of principal executive offices, including zip code)
 
 i (888)
 i 798-5802
 
(Registrant's telephone, including area code)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
 i ☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i ☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i ☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i ☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
Title of each class
Trading symbol
Name of each exchange on which registered
 i Common Stock
 i CDLX
 i The Nasdaq Stock Market LLC
 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
 i ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   i ☐
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
 




ITEM 2.02    RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On May 11, 2020, Cardlytics, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2020, as well as information regarding a conference call to discuss these financial results and the Company’s recent corporate highlights. The Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information included in this Item 2.02 and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.
ITEM 9.01    FINANCIAL STATEMENTS AND EXHIBITS
(d)    Exhibits
Exhibit
  
Exhibit Description
99.1
  
Press release dated May 11, 2020




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
Cardlytics, Inc.
 
 
 
 
Date:
May 11, 2020
By:
/s/ Andrew Christiansen
 
 
 
Andrew Christiansen
 
 
 
Chief Financial Officer
(Principal Financial and Accounting Officer)



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:5/11/2010-Q,  SC 13G/A
3/31/2010-Q,  4
 List all Filings 
↑Top
Filing Submission 0001666071-20-000127   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., Apr. 28, 12:29:43.1pm ET